Stay updated on Secured Access to Nivolumab for Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.

Latest updates to the Secured Access to Nivolumab for Rare Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.5.2 is displayed, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page revision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 was added to the site; the prior lapse-in-funding notice and Revision: v3.4.1 were removed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a site-wide notice about a lapse in government funding. Updated the revision to v3.4.1, replacing the previous v3.4.0 tag.SummaryDifference0.4%

- Check88 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Secured Access to Nivolumab for Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.